AV Molnupiravir
(Unterschied zwischen Versionen)
K |
K |
||
| Zeile 1: | Zeile 1: | ||
| − | {{up| | + | {{up|Candidate Compounds Covid19}} |
Molnupiravir, MK-4482, EIDD-2801 | Molnupiravir, MK-4482, EIDD-2801 | ||
*[https://www.infranken.de/ratgeber/gesundheit/coronavirus/covid19-medikament-blockiert-coronavirus-komplett-forscher-mit-durchbruch-art-5127468 Lokalpressebericht] | *[https://www.infranken.de/ratgeber/gesundheit/coronavirus/covid19-medikament-blockiert-coronavirus-komplett-forscher-mit-durchbruch-art-5127468 Lokalpressebericht] | ||
Version vom 22. Dezember 2020, 19:11 Uhr
| Candidate Compounds Covid19 |
Molnupiravir, MK-4482, EIDD-2801
- Lokalpressebericht
- clintrials molnupiravir
- Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets Acting through the induction of error catastrophe in virus replication4,12, NHC has broad-spectrum anti-RNA virus activity. In addition to ameliorating acute disease, we have demonstrated in a guinea pig transmission model that NHC effectively blocks the spread of influenza virus from infected animals to untreated contact animals.
- short editorial
